Privium Fund Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,132	Closed	-$1.76M	–	172
2022 Q3	$1.76M	Buy	17,132 +3,400	+25%	+$349K	0.64%	34
2022 Q2	$1.34M	Hold	13,732	–	–	0.44%	37
2022 Q1	$1.29M	Sell	13,732 -48,544	-78%	-$4.55M	0.28%	52
2021 Q4	$5.27M	Buy	+62,276	New	+$5.27M	1.05%	27